Tag: Healthcare Policy

Upcoming Changes in Title X Program Affecting Family Planning Services

Explore the impacts of upcoming changes in the Title X program on family planning services, funding, and essential health care access.

Public Engagement in Medicare Advantage Payment Rates: Insights and Concerns

Explore public feedback on proposed Medicare Advantage payment rates, revealing insights and concerns about health insurer funding and beneficiary services.

Impact of Medicare Advantage Plans on Part B Premiums and Social Security

Discover how Medicare Advantage plans are raising Medicare Part B premiums and affecting Social Security benefits for seniors, necessitating urgent reform.

Discussion on ACA Changes and Medicaid Impacts

Explore the impacts of recent healthcare policy changes on insurance coverage and costs, highlighting the need for ACA protection and increased federal support.

Overpayments to Medicare Advantage Plans: An Analysis

Discover the impact of Medicare Advantage overpayments and reforms needed to safeguard Part B premiums and benefits for millions of beneficiaries.

Challenges and Impacts of Medicaid Funding Cuts

Explore the challenges and impacts of Medicaid funding cuts on health insurance access and public health services. Understand the need for evidence-based policy evaluation.

Medicare Drug Price Negotiation Insights and Implications

Explore the implications of Medicare's Drug Price Negotiation Program, its impact on costs, and the ongoing negotiations for 2028. Discover key details.

Impact of HR.1 on TRICARE Beneficiaries and Healthcare Access

Explore how recent changes to Medicaid affect TRICARE beneficiaries and the healthcare access of service members and veterans due to financial risks of hospitals.

Rising Uninsured Rate in Minnesota: A Cause for Concern

Explore the alarming rise in uninsured residents in Minnesota and its implications for healthcare financing and policy changes.

Trump Administration Proposes MFN Deals in Pharmacy Sector

Explore the Trump administration's proposal on MFN agreements affecting pharmaceutical pricing and the ongoing regulatory developments in healthcare.